Should crizotinib be dosed to sinus bradycardia (SB) (HR < 55)? A single institution, retrospective analysis of heart rate (HR) changes and tumor response in crizotinib treated NSCLC patients.
Wilson P. Tong
No relevant relationships to disclose
Michele Azada
No relevant relationships to disclose
Sai-Hong Ignatius Ou
Consultant or Advisory Role - Pfizer
Research Funding - Pfizer